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PURPOSE: Patients with adult-onset idiopathic 
hypoparathyroidism (AOIH) often have antibod- 
ies against the parathyroid glands and other tis- 
sues, suggestive of immune activation. The pur- 
pose of this study was to determine whether 
T-cell activation is also a component of the en- 
docrine disease. 
PATIENTSANDMETHODS: Weidentifiedeight 
patients with idiopathic hypoparathyroidism di- 
agnosed after the age of 30 years at two tertiary 
care centers and evaluated peripheral blood 
lymphocyte subset phenotype frequencies using 
monoclonal antibodies and flow cytometry. Con- 
trol subjects were 13 patients with Graves’ dis- 
ease (five thyrotoxic and eight euthyroid) and 
110 healthy volunteers. In two of the patients 
with AOIH, we also determined the mitogenic 
response to parathyroid cell membranes in pe- 
ripheral lymphocytes. 
RESULTS: Patients with AOIH had higher than 
normal frequencies of the following phenotypes 
(p <0.05 versus controls, one-way analysis of 
variance): CD4, helper T cells, CD29/CD4, in- 
ducer of helper T cells, CD16 and CD56, natural 
killer cells; and CD3/DR, activated T cells coex- 
pressing DR. Patients with Graves’ disease had 
significantly higher than control frequencies of 
CD25 (T cells bearing the interleukin-2 recep- 
tor), CD3/DR, and CD26 (also a marker of T- 
cell activation); whereas the frequency of 
CD29/CD4 was significantly less than the con- 
trol frequency. Neither of the two AOIH pa- 
tients tested showed lymphocyte proliferation in 
response to parathyroid or thyroid cell mem- 
brane fractions. 
CONCLUSIONS: Generalized T-cell activation 
represents a novel feature associated with 
AOIH. Although we could not demonstrate para- 
thyroid-specific lymphocyte clonal expansion, 
these data are suggestive of a generalized im- 
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mune disturbance possibly related to autoimmu- 
nity, in which one of the manifestations is 
hypoparathyroidism. 
P atients with idiopathic hypoparathyroidism have a high frequency of circulating antibodies 
against the parathyroid glands and other tissues 
[l-4]. The antibodies, detected by immunofluores- 
cence, are mostly of the IgG and IgM isotypes, and 
are not found in patients with hypoparathyroidism 
after neck surgery [2]. Antiparathyroid antibodies 
have been reported in a pediatric population with 
idiopathic hypoparathyroidism [5], and in a subset 
of adults with the same disorder [2]. These findings 
suggested an autoimmune etiology, a concept fur- 
ther supported by the direct demonstration in vitro 
of a pathogenic effect in parathyroid tissue for anti- 
bodies of the IgG and IgM isotypes [2,3]. 
Autoimmunity is characterized by activation of T 
cells, clonal expansion of antigen-specific T cells, 
and production of autoantibodies by B cells [6]. If 
an autoimmune mechanism were operating in the 
pathogenesis of adult-onset idiopathic hypopara- 
thyroidism (AOIH), it might be possible to demon- 
strate lymphocyte phenotype alterations consistent 
with T-cell activation and parathyroid antigen-spe- 
cific clonal expansion. To this effect, the present 
study used monoclonal antibodies and flow cyto- 
metry to determine the expression of 14 different 
lymphocyte phenotype markers in peripheral blood 
cells of patients with AOIH (diagnosed after the age 
of 30 years), patients with Graves’ disease, and nor- 
mal healthy control subjects. We also investigated 
the mitogenic response of peripheral blood lympho- 
cytes to parathyroid and thyroid cell surface anti- 
gens. The results, consistent with generalized im- 
munoactivation in patients with AOIH, provide 
additional information on immune alterations asso- 
ciated with this condition. 
PATIENTS AND METHODS 
The clinical subjects were collected from the En- 
docrine Services at Southern Illinois University, 
Springfield, Illinois, and at Baylor College of Medi- 
cine, Houston, Texas. There were eight patients 
with AOIH, 13 with Graves’ disease, and 110 normal 
controls. The diagnosis of AOIH had been made in 
all cases by the combinations of: presentation after 
30 years of age, hypocalcemia with undetectable or 
normal parathyroid hormone levels, and absence of 
previous neck surgery or systemic disease known to 
affect the parathyroid glands. The age of onset 
ranged from 36 to 71 years, while at the time of the 
study, patients were 36 to 78 years old. Seven of the 
patients were male and one was female; two had 
coexisting Hashimoto’s thyroiditis, and one had 
Hashimoto’s thyroiditis, Addison’s disease, and hy- 
pogonadotropic hypogonadism. Six of the eight pa- 
tients had antibodies against parathyroid tissue, as 
detected by direct immunofluorescence [2]. At the 
time of the study, most patients were receiving vita- 
min D and calcium supplementation and had nor- 
mal blood calcium and phosphate levels. 
To match the presumed heterogeneity of dura- 
tion of idiopathic hypoparathyroidism, the Graves’ 
disease group included five patients with active dis- 
ease and eight with inactive disease, none of whom 
received antithyroid drugs. Patients with active 
Graves’ disease had clinical thyrotoxicosis, and 
their blood samples were drawn immediately before 
administration of radioiodine therapy. Patients 
with inactive Graves’ disease had been treated with 
13rI a year or more before testing and had developed 
permanent hypothyroidism. They were receiving 
replacement therapy with thyroid hormone. Con- 
trols were healthy individuals without known he- 
matologic disorders; 71 were female (11 to 80 years 
old) and 39 were male (24 to 67 years old). 
Blood samples were obtained locally in Spring- 
field, Illinois, from five hypoparathyroid patients, 
eight of the 13 patients with Graves’ disease, and 60 
controls. Samples from the remaining patients and 
controls were shipped from source in insulated sty- 
rofoam containers by overnight air express. All 
blood specimens were collected in EDTA-anticoa- 
gulated Vacutainers (Becton Dickinson, Ruther- 
ford, NJ) and were tested within 16 hours of veni- 
puncture. The absolute lymphocyte count was 
obtained and a buffy coat was prepared by centrifu- 
gation (5OOXg, 10 minutes), washing and resus- 
pending in 0.15 M phosphate-buffered saline (con- 
taining 0.1% sodium azide [PBSA]) at a 
concentration of approximately 2,000 lympho- 
cytes/ml. 
Staining with monoclonal antibodies was per- 
formed in 12 X 75-mm disposable glass tubes by 
adding 0.1 mL of washed, buffy coat lymphocytes to 
the manufacturer-suggested working volume of 
monoclonal antibodies, and incubating in the dark 
at 4°C for 30 minutes [7]. Unbound monoclonal 
antibodies were removed by two washes in PBSA 
(5OOXg, 3 minutes), and erythrocytes were lysed 
according to the Becton Dickinson protocol (Becton 
Dickinson, Mountain View, CA; source book, sec- 
tion 2.11). Lymphocytes were washed again in 
PBSA and fixed in 1% paraformaldehyde in PBSA 
for flow cytometry analysis. This was performed 
with a flow cytometer using a Biohazard flow tube 
and a 5-W laser exciting at 488 nm (Coulter Epics C, 
Coulter Immunology, Hialeah, FL). 
Monoclonal antibodies were labeled with fluores- 
cein isothiocyanate (FITC) or phycoerythrin (PE), 
and the test panel included: CD45 (FITC)/CD14 
(PE) (Coulter) for use in gating of lymphocytes 
(CD45) and exclusion of monocytes (CD14); T4 
(FITC) (Coulter) and Leu-3 (FITC) (Becton Dick- 
inson) to detect CD4 helper T cells; Leu-2 (PE) 
(Becton Dickinson) to detect CD8 suppressor/cyto- 
toxic lymphocytes; ILBR (FITC) (Becton Dickin- 
son) to detect interleukin-2 receptor-bearing T 
lymphocytes (used with CD5 [Tl PE] [Coulter] to 
restrict analysis to T cells); TAl (FITC) (Coulter) 
to detect activated T cells (CD26) in conjunction 
with CD5 as above; 2H4 (PE) (Coulter) to detect 
the suppressor/inducer phenotype (CD45RA) on 
helper T cells (CD4); 4B4 (PE) (Coulter) to detect 
the inducer of helper phenotype CD29 on CD4 cells; 
Leu-llb (FITC) (Becton Dickinson) to detect the 
Fc receptor on natural killer and K cells (CD16); 
and NKH-1 (PE) (Coulter) to detect natural killer 
cells (CD56); Leu-4 (FITC)/DR (PE) (Becton Dick- 
inson) and 13 (FITC)/TS (PE) (Coulter) to detect 
activated T cells coexpressing the MHC class II DR 
antigen. Isotype controls included: mouse IgGl 
(both FITC- and PE-labeled) and IgG2a (FITC, and 
PE). 
After the bit map and color compensation were 
set, a minimum of 2,000 lymphocytes were analyzed 
for each phenotype determination. 
Tissue Collection 
Samples of adenomatous parathyroid glands, 
Graves’ disease (not treated with antithyroid drugs) 
thyroid glands, and normal liver were obtained at 
the time of surgery, snap-frozen in liquid nitrogen, 
and stored at -70°C until tested. Plasma mem- 
branes produced by mechanical homogenization 
were separated from nuclei by centrifugation 
(1,5OOXg, 20 minutes). The supernatant was then 
centrifuged on a continuous Percoll gradient 
(3O,OOOXg, 25 minutes) and fractions containing 5’- 
nucleotidase were pooled and used. Protein concen- 
tration was measured by a modification of the Coo- 
masie brilliant blue dye-binding assay [a]. Purified 
bovine thyroglobulin was obtained from a commer- 
cial source (Sigma, St. Louis, MO). 
Lymphocyte Stimulation Assay 
Peripheral blood mononuclear cells (PBMC) 
were obtained by standard Ficoll-Hypaque centrif- 
ugation methods from two patients with AOIH: one 
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with isolated hypoparathyroidism (Patient 1) and 
the other with hypoparathyroidism and hypothy- 
roid Hashimoto’s thyroiditis (Patient 2). The 
PBMC were cultured in RPMI-1640 tissue culture 
medium (Hepes buffer) as described previously [7]. 
The PBMC were cultured with the following mito- 
gens: phytohemagglutinin (PHA) 0.5 pg/mL, para- 
thyroid cell membranes at protein concentrations 
of 1, 10, and 20 pg/mL, thyroid cell membranes at 20 
pg/mL, thyroglobulin at 10 pg/mL, liver cell mem- 
branes at 20 pg/mL, and phosphate-buffered saline 
as a background control. After 72 hours of incuba- 
tion in 5% carbon dioxide in air at 95% humidity at 
37”C, the PBMC cultures were pulsed for 18 hours 
with one &i/well of 3H-thymidine (New England 
Nuclear, Boston, MA), harvested onto glass fiber 
filter papers, and washed. The 3H incorporation 
was determined by scintillation spectroscopy. All 
cultures were performed in quadruplicate. 
Statistical Analysis 
The statistical significance of differences be- 
tween groups was evaluated by one-way analysis of 
variance (ANOVA). The Tukey-HSD procedure 
was used as a follow-up test; the significance level 
was set at p = 0.05. 
RESULTS 
Typical flow cytometry patterns for CD4 and 
CD29 in representative patients for each clinical 
group are presented in Figure 1. The horizontal 
axes of the single-color histograms, i.e., a and b, 
represent fluorescence intensity increasing to the 
right, and the vertical axes represent the proportion 
of measured events at each fluorescence intensity. 
Events to the right of the vertical cursors are con- 
Figure 1. Representative histo- 
grams of flow cytometry demon- 
strating intraindividual consistency 
for CD4 (as detected by Leu-3 and 
T4 antibodies) and CD4/CD29 
(T4/4B4). Histograms a, b, and c 
correspond to a patient with AOIH; 
d, e, and f to a patient with Graves’ 
disease; and g, h, and i to a normal 
control subject. On histograms c, f, 
and i, the percent value in the up- 
per right quadrant represents dou- 
ble-stained lymphocytes; the hori- 
zontal axes represent relative fluo- 
rescence intensity and the vertical 
axes the number of cells positive. 
The horizontal axes of the quadrant 
histograms represent green fluo- 
rescence intensity and the vertical 
axes red fluorescence intensity. 
sidered positive. In the two-color histograms, i.e., c, 
the horizontal axes represent relative intensity of 
green fluorescence and the vertical axes red fluores- 
cence. The vertical and horizontal cursors discrimi- 
nate between background and positive events. 
Events in the upper right quadrants represent cells 
with both green and red fluorescence. 
Of the 13 lymphocyte phenotype frequencies 
tested in the three groups, there were no significant 
differences between any pairs of the three groups 
for the following: CDB, CD3, CD26/CD4 (coex- 
pressed), CD45RA/CD4, CD16/CD56, and the ratio 
of CD4:CDB. Of the two monoclonal antibody com- 
binations used to detect CD3/DR, 13/T3 (Coulter) 
and Leu-4/DR (Becton Dickinson), the frequency 
of Leu-4/DR did not differ significantly in any com- 
parison (Table I), but the 13/T3 combination was 
significantly affected by diagnostic category. 
Significant differences (p <0.05, one-way ANO- 
VA) between controls and patients with AOIH were 
observed for the following phenotypes (Table II): 
CD4 (helper T cells); CD29/CD4 (inducer of helper 
T cells); and CD16 and CD56 (natural killer and K 
cells). The frequencies of all these phenotypes were 
significantly higher in patients with AOIH than in 
control subjects. An activation marker for T cells, 
the expression of DR, was also significantly elevat- 
ed in the AOIH group, but only when assessed with 
the Coulter monoclonal antibodies 13/T3. 
The CD5/CD20 phenotype, a presumed marker 
for B cells involved in autoimmunity [9], was also 
tested in two of the hypoparathyroid patients and 
found within the control range (data not shown). 
No lymphocyte phenotype frequency differed 
significantly between the patients with active and 
inactive Graves’ disease, but when both groups of 
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TABLE I 
Lymphocyte Phenotype Frequencies Not Differing Significantly 
Between Groups* 
TABLE II 
Lymphocyte Phenotype Frequencies Differing Significantly Between 
Groups 
% Total Lymphocytes Positive* 
Phenotype Hypoparathyroid Graves’ Controls 
CD4 52.3 (6.3)+ 42.4 (10.9) 40.1 (9.8)+ 
CD29/CD4 40.4 (6.3)t' 30.4 (11.4)+ 32.1 (8.211 
CD25 6.7 (3.1) 8.2 (3.7)+ 4.8 (3.9)+ 
CD26 14.3 (5.8) 16.4 (5.2)t 10.8 (6.6)t 
CD3IDR 9.1 (4.711 6.9 (4.1)+ 3.2 (1.8)+* 
CD16 16.0 (17.7)+ 13.6 (8.2) 8.7 (6.0)? 
CD56 18.3 (16.1)? 11.2 (5.01 9.7 (6.1)+ 
*Standard deviation In parentheses. 
tiDenotes pairs of groups that differ significantly at p ~0.05, by one-way analysis of variance. 
Phenotype 
% Total Lymphocytes Positive+ 
Hypoparathyroid Graves’ Controls 
CD3 71.8 (8.6) 60.6 (17.3) 62.6 (12.6) 
CD8 27 (10.5) 20.7 (7.1) 23.1 (7.1) 
CD4:CD8 2.25 (1.12) 2.22 (0.81) 1.87 (0.73) 
!!3!DR(Leu-4) 1;:; I;.:; 
(3:8) 
2.1 9.4 (5.2) 2 11.4 .9 (1.1) (4.9) 
CD26iCD5 9.9 13.5 (5.3) 10.4 (3.8) 
CD16iCD56 12.7 (13.6) 8.2 (4.7) 8.8 (3.4) 
CD45RAiCD4 27.9 (12.9) 19.8 (11.8) 21.8 (11.5) 
*p >0.05 for all intergroup differences (one-way analysis of variance). 
tstandard deviation in oarentheses. 
Graves’ patients were considered together, several 
phenotype frequencies differed significantly from 
those in the normal controls. Thus, Graves’ disease 
was characterized by T-cell activation as demon- 
strated by significantly higher than control fre- 
quencies of CD25 (the interleukin-2 receptor mark- 
er), CD26 (the activated T-cell marker), and 
CD3/DR (13/T3). Only one phenotype, CD29/CD4 
(inducer of helper), differed significantly between 
the patients with Graves’ disease and the hypopara- 
thyroid patients (Table II). 
The mitogenic responses of lymphocytes to tissue 
membrane fractions determined in two patients 
with AOIH are presented in Figures 2 and 3. In 
Patient 1, parathyroid membranes did not stimu- 
late 3H-thymidine incorporation nor did any of the 
other membrane fractions tested (Figure 2). Patient 
Figure 2. Lymphocyte proliferation response (3H-thymidine 
incorporation) to parathyroid and thyroid membrane and 
thyroglobulin (TG) in a patient with isolated AOIH. Antigen 
concentration is expressed in rg protein/ml. None of the re- 
sponses differed significantly from those in controls (p 
>0.05). PTM = parathyroid membrane; HTM = human thy- 
roid membrane. 
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2, who had Hashimoto’s thyroiditis, demonstrated a 
slight but not statistically significant mitogenic re- 
sponse to thyroglobulin and absent response to thy- 
roid or parathyroid membranes (Figure 3). Both 
subjects responded significantly to PHA 0.5 pg/mL 
(500-fold increase) but not to liver membranes 
(data not shown). 
The present study, performed on peripheral lym- 
phocytes from patients with AOIH, shows a pattern 
of T-cell activation. Thus, the accumulated evi- 
dence suggests a syndrome of immune dysfunction 
in AOIH, in common with the recognized autoim- 
mune disorder Graves’ disease [lo]. Most impor- 
tantly, patients with AOIH have a higher than nor- 
mal frequency of the CD3/DR phenotype 
representing T-cell activation. Although the natu- 












Figure 3. Lymphocyte proliferation response in a patient with 
AOIH and Hashimoto’s thyroiditis. None of the responses 
were significantly different from those in controls. PTM = 
parathyroid membrane; HTM = human thyroid membrane; 
TG = thyroglobulin. 
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AOIH, the significance of this finding is unclear. 
Natural killer cells [ll] have recently been found to 
bind thyrotropin (TSH) in vitro [12], but specific 
TSH receptors were not characterized in that study 
WI. 
Evidence for B-cell activation was not observed 
in this study, despite the high incidence of autoanti- 
bodies known to be present in patients with idio- 
pathic hypoparathyroidism in general [4], and espe- 
cially in AOIH [2]. However, caution must be taken 
in interpreting this finding, since B-cell activation 
was also absent in Graves’ disease, where immuno- 
globulins against the TSH receptor are the direct 
cause of hyperthyroidism [lo]. Moreover, the pres- 
ence of polyreactive IgM autoantibodies may not 
necessarily imply autoimmune disease, since such 
antibodies have been found to occur naturally in 
nonimmunized mice and in humans [13,14]. 
An important question that remains unanswered 
is the nature of the antigenic stimulus that triggers 
T-cell activation in AOIH. If that were primarily 
determined by a parathyroid component, it would 
be difficult to understand the observed generalized 
immune activation in response to such a small anti- 
gen mass. We nevertheless performed additional 
experiments specifically addressed to evaluating 
such a possibility. Using viable lymphocytes, as 
confirmed by their appropriate response to PHA, 
we did not find mitogenic responses in AOIH lym- 
phocytes co-cultured with parathyroid cell mem- 
branes. Most likely, these findings imply that pe- 
ripheral lymphocytes are not actively involved in 
the pathogenesis of the hypoparathyroidism but re- 
flect an underlying state of nonspecific immune ac- 
tivation. Alternate possibilities include the absence 
of a normal constituent (parathyroid membrane 
antigen) from the parathyroid adenoma-derived 
preparation used to stimulate the lymphocytes, or 
immune activation by a parathyroid antigen not 
accessible to the lymphocytes without prior enzy- 
matic digestion or other procedures that may un- 
mask a cryptic antigen. 
Surprisingly, the generalized T-cell activation 
was more extensive in idiopathic hypoparathyroid- 
ism than in Graves’ disease. Although the lympho- 
cyte phenotype pattern generally reflects activation 
in Graves’ disease [10,15,16], subset frequencies in 
that disease were found to be intermediate between 
AOIH and controls. Of note, no differences in T-cell 
phenotypic profiles were noted between active and 
quiescent Graves’ disease, an area in which consen- 
sus has not been reached [lo]. 
Taken together, the present findings and previ- 
ous reports [l-4] further help define AOIH. While 
the idiopathic label still remains for the primary 
trigger of the disease, it now appears that the im- 
mune system may be consistently abnormal, per- 
haps as the main mediator or at least a significant 
contributor in the pathogenesis of hypoparathy- 
roidism. Clearly, T-cell activation and a humoral 
reaction are also components of AOIH, with the 
importance of the latter having already received 
partial confirmation. Thus, circulating anti- 
parathyroid antibodies do have pathogenic activity 
in vitro, as documented by the production of para- 
thyroid cell lysis [3] or interference with the signal 
recognition/transduction mechanism responsible for 
calcium-regulated parathyroid hormone secretion [2]. 
In conclusion, the novel feature of T-cell activa- 
tion in AOIH should be added to the immune ab- 
normalities already reported in these patients. The 
present results suggest that AOIH may be the result 
of a generalized immune disturbance in which hy- 
poparathyroidism is one manifestation. 
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